Jerome Stevens Pharmaceuticals
News & Press Careers Employee Portal Contact
Products Unithroid
About Us
Products Products Unithroid News & PressCareers About About Us Employee PortalContact
Jerome Stevens Pharmaceuticals
Jerome Stevens Pharmaceuticals Announces Acquisition of Thyquidity® (Levothyroxine Sodium Oral Solution)
AdminApril 1, 2025
Amneal Announces 10-Year Licensing and Supply Agreement with Jerome Stevens Pharmaceuticals, Inc. for Levothyroxine
Amneal Announces 10-Year Licensing and Supply Agreement with Jerome Stevens Pharmaceuticals, Inc. for Levothyroxine
Joe DomanteOctober 30, 2018
Jerome Stevens Pharmaceuticals,has ample supply to combat the announced shortage of Levoxyl©.
Jerome Stevens Pharmaceuticals,has ample supply to combat the announced shortage of Levoxyl©.

Jerome Stevens Pharmaceuticals, Inc., manufacturer of Unithroid©, the first FDA-approved Levothyroxine Sodium, USP therapy, announced today that it has ample supply to combat the announced shortage of Levoxyl©.

Read More
Joe DomanteSeptember 16, 2018
JEROME STEVENS PHARMACEUTICALS, INC.
60 Davinci Drive,
Bohemia, NY, 11716,
United States
inquiries@jeromestevens.com
Hours
Mon Open
Tue Open
Wed Open
Thu Open
Fri Open
Sat Closed
Sun Closed
 
JSP-LOGO-FINAL.png

JEROME STEVENS PHARMACEUTICALS, INC. © 2022  — Site Design by Brooklyn Creative

Products
JSP Products Unithroid
Learn More
News & Press About
CareersEmployee PortalPrivacy PolicyDisclaimer